Insight – US to temporarily reduce regulatory barriers for infant formula imports


The US Food and Drug Administration (FDA) intends to temporarily reduce the regulatory requirements for infant formula imports. The move is an effort to increase the supply of infant formula in the US.

Implications for exporters

Australian infant formula exporters may wish to consider supplying the US market given high demand and reduced regulatory barriers.

Interested infant formula exporters should respond promptly to this time-sensitive project.

Exporters should review FDA guidance material

/Public Release. This material from the originating organization/author(s) may be of a point-in-time nature, edited for clarity, style and length. The views and opinions expressed are those of the author(s).View in full here.